Home >> Marketplace Directory >> Inova launches next-gen EIA/IFA processor, 3/18

Inova launches next-gen EIA/IFA processor, 3/18

image_pdfCreate PDF

 

March 2018—Inova Diagnostics announced the launch of its Quanta-Lyser 3000, a fully automated enzyme-linked immunoassay and immunofluorescence assay processor for use in clinical laboratories.

The system features a 240 capacity sample deck and four independently operating probes. The processor improves assay traceability for EIA and IFA protocols using an onboard camera that automatically scans 2-D reagent barcodes. The barcodes provide reagent identity, lot number, and expiration date information from Inova reagents. The camera automatically scans Nova Lite IFA slide barcodes to ensure positive patient identification throughout processing and creates a paperless workflow for EIA and IFA testing. Individual well washing and the ability to pipette IFA slide-mounting media further automate testing. IFA slides are processed in proprietary carriers that can be directly transferred to Nova View, an automated digital IFA microscope.

Inova Diagnostics, 858-586-9900

CAP TODAY
X